SCHEMBL4891091

SCHEMBL4891091

CCc1cnc(-c2cccc(Br)n2)s1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 1/20 0.34
ZAP70 P43403 1/20 0.34
SYK P43405 1/20 0.34
ALDH1A1 P00352 2/20 0.33
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
AGTR1 P30556 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CCNE1 P24864 1/20 0.33
CDK2 P24941 1/20 0.33
CDK5 Q00535 1/20 0.33
HTR7 P34969 1/20 0.33
GABRA1 P14867 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA3 P34903 1/20 0.32
KDR P35968 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13622982 0.81 ASIC3 (0.40) SRCZAP70SYKALDH1A1MAPT
SCHEMBL4903147 0.79 SRC (0.43) SRCZAP70SYKALDH1A1NPC1
SCHEMBL4899157 0.76 CCNE1 (0.35) ALDH1A1SMN1; SMN2CCNE1CDK2CDK5
SCHEMBL12112308 0.76 ALDH1A1 (0.54) ALDH1A1NPC1LMNAMAPTAGTR1
SCHEMBL4896523 0.76 GABRA1 (0.37) ALDH1A1GABRA1GABRG2GABRB3GABRA3
SCHEMBL4896924 0.74 KMT2A (0.42) SRCZAP70SYKALDH1A1NPC1
SCHEMBL10988411 0.72 HTR2C (0.47) ALDH1A1NPC1LMNAMAPTSMN1; SMN2
SCHEMBL26759340 0.70 XDH (0.44) NPC1LMNARAB9ASMN1; SMN2L3MBTL1
SCHEMBL17717288 0.70 RAB9A (0.39) SRCZAP70SYKALDH1A1NPC1
SCHEMBL153089 0.69 CYP11B1 (0.56) ALDH1A1NPC1LMNAMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080108600-A1 Polycyclic Pyridines as Potassium Ion Channel Modulators ICAGEN, INC. (US) 2008-05-08 US disclosed
CN-1980923-A Polycyclic pyridines as potassium ion channel modulators ICAGEN INC (US) 2007-06-13 CN disclosed
EP-1737852-A2 POLYCYCLIC PYRIDINES AS POTASSIUM ION CHANNEL MODULATORS Icagen, Inc. (US) 2007-01-03 EP disclosed
WO-2005100349-A2 POLYCYCLIC PYRIDINES AS POTASSIUM ION CHANNEL MODULATORS ICAGEN, INC. (US) 2005-10-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080108600-A1 Polycyclic Pyridines as Potassium Ion Channel Modulators KCNJ2, KCNH2, KCNQ1 SRC 4155/4885ZAP70 3314/4885SYK 4140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.